Release Date: 16/09/10 09:58 Summary: Appendix 3B - Exercise of Options Price Sensitive: No Download Document 203.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%